Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.
In rat models, CD4(+)CD25(+) T regulatory cells (Treg) play a key role in the induction and maintenance of antigen-specific transplant tolerance, especially in DA rats with PVG cardiac allografts (1, 2). We have previously described generation of alloantigen-specific Treg (Ts1), by culture of naïve natural CD4(+)CD25(+) Treg (nTreg) with specific alloantigen and IL-2 for 4 days. These cells express mRNA for IFN-γ receptor (ifngr) and suppress donor but not third party cardiac allograft rejection mediated by alloreactive CD4(+) T cells at ratios of <1:10. Here, we show that Ts1 also expressed the IL-12p70 specific receptor (il-12rβ2) and that rIL-12p70 can induce their proliferation. Ts1 cells re-cultured with rIL-12p70 alone or rIL-12p70 and recombinant interleukin-2 (rIL-2), suppressed proliferation of CD4(+) T cells in mixed lymphocyte culture at <1:1024, whereas Ts1 cells re-cultured with rIL-2 and alloantigen only suppressed at 1:32-64. The rIL-12p70 alloactivated Ts1 cells markedly delayed PVG, but not third party Lewis, cardiac allograft rejection in normal DA recipients. Ts1 cells re-cultured for 4 days with rIL-12p70 alone, but not those re-cultured with rIL-12p70 and rIL-2, expressed more il-12rβ2, t-bet, and ifn-γ, and continued to express the markers of Ts1 cells, foxp3, ifngr, and il-5 indicating Th1-like Treg were induced. Ts1 cells re-cultured with rIL-2 and alloantigen remained of the Ts1 phenotype and did not suppress cardiac graft rejection in normal DA rats. We induced highly suppressive Th1-like Treg from naïve nTreg in 7 days by culture with alloantigen, first with rIL-2 then with rIL-12p70. These Th1-like Treg delayed specific donor allograft rejection demonstrating therapeutic potential.
Immune Tolerance Laboratory, Department of Medicine, Liverpool Hospital, University of New South Wales , Kensington, NSW , Australia.
Nirupama Darshan
ND
Verma
Immune Tolerance Laboratory, Department of Medicine, Liverpool Hospital, University of New South Wales , Kensington, NSW , Australia.
Bruce Milne
BM
Hall
Immune Tolerance Laboratory, Department of Medicine, Liverpool Hospital, University of New South Wales , Kensington, NSW , Australia.
Karren Michelle
KM
Plain
Immune Tolerance Laboratory, Department of Medicine, Liverpool Hospital, University of New South Wales , Kensington, NSW , Australia.
Catherine M
CM
Robinson
Immune Tolerance Laboratory, Department of Medicine, Liverpool Hospital, University of New South Wales , Kensington, NSW , Australia.
Rochelle
R
Boyd
Immune Tolerance Laboratory, Department of Medicine, Liverpool Hospital, University of New South Wales , Kensington, NSW , Australia.
Giang T
GT
Tran
Collaborative Transplant Research Laboratory, Royal Prince Alfred Hospital, The University of Sydney , Camperdown, NSW , Australia.
Chuanmin
C
Wang
Collaborative Transplant Research Laboratory, Royal Prince Alfred Hospital, The University of Sydney , Camperdown, NSW , Australia.
G Alex
GA
Bishop
Immune Tolerance Laboratory, Department of Medicine, Liverpool Hospital, University of New South Wales , Kensington, NSW , Australia.
Suzanne J
SJ
Hodgkinson
IL-12p70; T regulatory cells; Th1-like Treg; allograft rejection; antigen-specific Treg